FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

64907011000036108: monobasic potassium phosphate (AU substance)


Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
392134011000036112 monobasic potassium phosphate (AU substance) en Fully specified name Active Case sensitive Australian Medicines Terminology module
392135011000036111 monobasic potassium phosphate en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
monobasic potassium phosphate Is a medicinal substance true Inferred relationship Some
monobasic potassium phosphate is modification of phosphorus true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
thiamine + riboflavin + nicotinamide + pantothenic acid + pyridoxine + cyanocobalamin + biotin + ascorbic acid + d-alpha-tocopherol + magnesium + calcium phosphate + monobasic potassium phosphate + folic acid + avena sativa extract + passiflora incarnata extract + lecithin + choline bitartrate + inositol has intended active ingredient False monobasic potassium phosphate Inferred relationship Some
Executive B Stress Formula (ascorbic acid 130 mg + Avena sativa extract 25 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg) tablet (trade product unit of use) has intended active ingredient False monobasic potassium phosphate Inferred relationship Some 1422671666
Executive B Stress Formula (ascorbic acid 130 mg + Avena sativa extract 25 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg) tablet (trade product unit of use) has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 1422671666
ascorbic acid 130 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg (50 units) + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + oat extract 25 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg tablet has intended active ingredient False monobasic potassium phosphate Inferred relationship Some 781442992
ascorbic acid 130 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg (50 units) + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + oat extract 25 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg tablet has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 781442992
Executive B Stress Formula (ascorbic acid 130 mg + Avena sativa extract 25 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg) tablet (trade product unit of use) has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 668008123
ascorbic acid 130 mg + biotin 20 microgram + calcium ascorbate dihydrate 145 mg + calcium pantothenate 75 mg + calcium phosphate 100 mg + choline bitartrate 25 mg + cyanocobalamin 30 microgram + d-alpha-tocopheryl acid succinate 41.3 mg (50 units) + folic acid 150 microgram + inositol 25 mg + lecithin 50 mg + magnesium phosphate pentahydrate 140 mg + monobasic potassium phosphate 117.3 mg + nicotinamide 100 mg + oat extract 25 mg + passiflora incarnata extract 20 mg + pyridoxine hydrochloride 25 mg + riboflavin 10 mg + thiamine hydrochloride 75 mg tablet has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 1569433987
monobasic potassium phosphate has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 1
dibasic potassium phosphate + monobasic potassium phosphate has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 1
Potassium Dihydrogen Phosphate (DBL) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 1122529182
Potassium Dihydrogen Phosphate (DBL) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 1122529182
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 456887362
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 456887362
dibasic potassium phosphate 1.053 g/10 mL + monobasic potassium phosphate 1.093 g/10 mL (total potassium 20 mmol/10 mL) injection, vial has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 1856435934
dibasic potassium phosphate 1.053 g/10 mL + monobasic potassium phosphate 1.093 g/10 mL (total potassium 20 mmol/10 mL) injection, vial has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 1856435934
dibasic potassium phosphate 1.83 g/10 mL + monobasic potassium phosphate 540 mg/10 mL (total potassium 25 mmol/10 mL) injection, ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 2008857118
dibasic potassium phosphate 1.83 g/10 mL + monobasic potassium phosphate 540 mg/10 mL (total potassium 25 mmol/10 mL) injection, ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 2008857118
Potassium Dihydrogen Phosphate and Dipotassium Hydrogen Phosphate (DBL) injection, 10 mL ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 185991966
Potassium Dihydrogen Phosphate and Dipotassium Hydrogen Phosphate (DBL) injection, 10 mL ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 185991966
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, vial has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 868951618
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, vial has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 868951618
Potassium Phosphate (Phebra) injection, 10 mL vial has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 1852495774
Potassium Phosphate (Phebra) injection, 10 mL vial has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 1852495774
Potassium Dihydrogen Phosphate (Phebra) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL vial has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 979812962
Potassium Dihydrogen Phosphate (Phebra) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL vial has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 979812962
dibasic potassium phosphate 1.83 g/10 mL + monobasic potassium phosphate 540 mg/10 mL (total potassium 25 mmol/10 mL) injection, ampoule has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 1790077673
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, ampoule has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 1315428489
dibasic potassium phosphate 1.053 g/10 mL + monobasic potassium phosphate 1.093 g/10 mL (total potassium 20 mmol/10 mL) injection, vial has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 1379352489
monobasic potassium phosphate 1.361 g (potassium 10 mmol)/10 mL injection, vial has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 2021457545
Potassium Dihydrogen Phosphate and Dipotassium Hydrogen Phosphate (DBL) injection, 10 mL ampoule has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 47764457
Potassium Phosphate (Phebra) injection, 10 mL vial has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 698730391
Potassium Dihydrogen Phosphate (DBL) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL ampoule has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 2095763561
Potassium Dihydrogen Phosphate (Phebra) 1.361 g (potassium 10 mmol)/10 mL injection, 10 mL vial has Australian BoSS False monobasic potassium phosphate Inferred relationship Some 1609391721
dibasic sodium phosphate + monobasic potassium phosphate has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 2
dibasic sodium phosphate dodecahydrate 3.84 g/20 mL + monobasic potassium phosphate 348 mg (potassium 2.6 mmol)/20 mL injection, ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 373261678
dibasic sodium phosphate dodecahydrate 3.84 g/20 mL + monobasic potassium phosphate 348 mg (potassium 2.6 mmol)/20 mL injection, ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 373261678
Sodium Phosphate and Potassium Phosphate (DBL) injection, 20 mL ampoule has Australian BoSS True monobasic potassium phosphate Inferred relationship Some 572896282
Sodium Phosphate and Potassium Phosphate (DBL) injection, 20 mL ampoule has intended active ingredient True monobasic potassium phosphate Inferred relationship Some 572896282

This concept is not in any reference sets

Back to Start